RELAÇÃO ENTRE ANSIEDADE, CRENÇAS NA MEDICAÇÃO E ADESÃO À TERAPÊUTICA EM DOENTES COM DOENÇA CARDIOVASCULAR

Autores

  • Raquel Coelho Hospital Garcia de Horta, Almada, Portugal; Nova Medical School, Lisboa, Portugal
  • Maria Teresa Herdeiro Departamento de Ciências Médicas, Instituto de Biomedicina (iBiMED), Universidade de Aveiro, Portugal
  • Isabel Vitória Figueiredo Laboratório de Farmacologia e Cuidados Farmacêuticos, Faculdade de Farmácia, Universidade de Coimbra; Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
  • Ana C. Cabral Laboratório de Farmacologia e Cuidados Farmacêuticos, Faculdade de Farmácia, Universidade de Coimbra; Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal

DOI:

https://doi.org/10.58043/rphrc.128

Palavras-chave:

Adesão à terapêutica, Ansiedade, Crenças à Medicação, Doenças Cardiovasculares

Resumo

Introdução: As doenças cardiovasculares são um grupo de patologias muito prevalentes em Portugal. Os transtornos de ansiedade, a adesão à terapêutica e as crenças que os doentes têm sobre a sua medicação são reconhecidos fatores de risco que afetam o controlo das doenças cardiovasculares, sendo por isso importante serem avaliados aquando da monitorização destes doentes.
Objetivos: Este estudo teve como objetivo identificar quais as ferramentas para avaliar e medir adesão à terapêutica anti-hipertensora, crenças na medicação e transtornos de ansiedade, devidamente validadas para a população portuguesa. Materiais e métodos: Foi realizada uma revisão da literatura sobre os questionários existentes para avaliar estas três dimensões. Foram avaliadas as propriedades psicométricas de cada questionário. Posteriormente, foi feita uma seleção de qual o mais adequado para cada um dos três parâmetros.
Resultados: Com a pesquisa realizada foi possível encontrar 5 questionários para medir adesão à terapêutica (HBCS, MUAH, MUAH-16, MAT e MMAS-8), 2 questionários para medir crenças na medicação (BMQ-Specific e B-IPQ) e 4 questionários para medir transtornos de ansiedade (BAI, HADS-A, SHAI e STAI) em doentes portugueses.
Conclusão: Os questionários HBCS, BMQ-Specific e BAI foram identificados como ferramentas úteis na prática clínica, de fácil aplicação e sem custos adicionais. Deste modo, esperamos contribuir para uma melhor identificação de doentes de risco, para que sejam definidas estratégias de intervenção mais individualizadas e mais eficazes na melhoria do controlo das doenças cardiovasculares.

Downloads

Não há dados estatísticos.

Referências

World Health Organization. Cardiovascular Diseases (CVDs). https://www.who.int/news-room/fact-sheets/ detail/cardiovascular-diseases-(cvds). Published 2017. Accessed January 27, 2020.

McGraw Hill. Medicina Interna de Harrison. 18th ed.; 2013.

Almeida JM, Xavier M, Cardoso G, et al. Estudo Epidemiológico Nacional de Saúde Mental. Lisboa: Faculdade de Ciências Médicas, Universidade Nova de Lisboa; 2013.

Barnhill JW. Considerações gerais sobre transtornos de ansiedade. Manual MSD. https://www.msdmanuals. com/pt-pt/casa/distúrbios-de-saúde-mental/ansiedade-e-transtornos-relacionados-ao-estresse/considerações-gerais-sobre-transtornos-de-ansiedade#. Accessed September 23, 2019.

Harvard Medical School. Anxiety and heart disease: A complex connection. Harvard Heal Publ. 2017:3-5. https://www.health.harvard.edu/heart-health/anxiety-and-heart-disease-a-complex-connection.

Batelaan NM, Seldenrijk A, Bot M, Van Balkom AJLM, Penninx BWJH. Anxiety and new onset of cardiovascular disease: Critical review and meta-analysis. Br J Psychiatry. 2016;208(3):223-231. doi:10.1192/bjp. bp.114.156554

Burnier M, Egan BM. Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management. Circ Res. 2019;124(7):1124-1140. doi:10.1161/CIRCRESAHA.118.313220

Carvalho E. Métodos de avaliação da adesão à terapêutica medicamentosa. Univ DA BEIRA Inter Ciências da Saúde. 2015:153.

Leite SN, Vasconcellos M da PC. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Cien Saude Colet. 2003;8(3):775-782. doi:10.1590/s1413-81232003000300011

Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76(2-3):157-163. doi:10.1016/S0167-5273(00)00374-0

Gentil L, Vasiliadis HM, Préville M, Bossé C, Berbiche D. Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults. J Am Geriatr Soc. 2012;60(12):2297-2301. doi:10.1111/j.1532-5415.2012.04239.x

Chatziefstratiou A, Giakoumidakis K, Fotos N V. Scales for assessing medication adherence in patients with hypertension. Br J Nurs. 2019;28(21).

Müller S, Kohlmann T, Wilke T. Validation of the Adherence Barriers Questionnaire – an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res. 2015. doi:10.1186/s12913-015-0809-0

González-bueno J, Calvo-cidoncha E, Sevilla-sánchez D. Traducción y adaptación transcultural al español del cuestionario ARMS para la medida de la adherencia en pacientes pluripatológicos. Atención Primaria. 2017;49(8):459-464. doi:10.1016/j. aprim.2016.11.008

Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and Evaluation of the Adherence to Refills and Medications Scale ( ARMS ) among Low-Literacy Patients with Chronic Disease. Value Heal. 2009;12(1):118-123. doi:10.1111/j.1524-4733.2008.00400.x

Nguyen T, Caze A La, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2012. doi:10.1111/bcp.12194

Pareja E, Elisabeth M, Prados E, Martínez F, José M, Corpas PG. Questionnaires on adherence to antihypertensive treatment : a systematic review of published questionnaires and their psychometric properties. Int J Clin Pharm. 2020;(0123456789). doi:10.1007/s11096-020-00981-x

Culig J, Leppée M. From Morisky to Hill-Bone ; Self-Reports Scales for Measuring Adherence to Medication. 2014;38:55-62.

Ranasinghe P, Jayawardena R, Katulanda P, Constantine GR, Ramanayake V, Galappatthy P. Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus. J Diabetes Res. 2018;2018. doi:10.1155/2018/7519462

Song Y, Han H, Song H, Nam S, Nguyen T, Kim MT. Psychometric Evaluation of Hill-Bone Medication Adherence Subscale. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5(3):183-188. doi:10.1016/j.anr.2011.09.007

Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2013:90-94. doi:10.1331/ JAPhA.2011.09154

Nogueira-Silva L, Sá-Sousa A, Lima MJ, Monteiro A, Dennison-Himmelfarb C, Fonseca JA. Translation and cultural adaptation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale to Portuguese. Rev Port Cardiol. 2016;35(2).

Weinman J, Graham S, Canfield M, et al. The Intentional Non-Adherence Scale (INAS): Initial development and validation. J Psychosom Res. 2018;115(August):110-116. doi:10.1016/j. jpsychores.2018.10.010

Zidan A, Awaisu A, Hasan S, Kheir N. The Living with Medicines Questionnaire :Translation and Cultural Adaptation into the Arabic Context. Value Heal Reg Issues. 2016;10:36-40. doi:10.1016/j.vhri.2016.07.001

Cabral AC, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo I V. Developing an adherence in hypertension questionnaire short version: MUAH-16. J Clin Hypertens. 2018;20(1):118-124. doi:10.1111/jch.13137

Wetzels G, Nelemans P, Wijk B Van, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: Development and validation of the ‘“Maastricht Utrecht Adherence in Hypertension (MUAH) -questionnaire.”’ 2006;64:151-158.

Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241-247.

Sowunmi O, Onifade P. Psychometric Evaluation of Medication Adherence Rating Scale (MARS) among Nigerian Patients with Schizophrenia. Niger J Clin Pract. 2019:1281-1285. doi:10.4103/njcp.njcp

Vanelli I, Chendo I, Gois C, Santos J, Levy P. Adaptação e Validação da Versão Portuguesa da Escala de Adesão à Terpêutica. Acta Med Port. 2011:2009-2012.

Unni EJ, Olson JL, Farris KB. Revision and validation of Medication Adherence Reasons Scale (MAR-Scale). Curr Med Res Opin. 2014;30(2):211-221. doi:10.1185/0 3007995.2013.851075

Scribano ML, Caprioli F, Michielan A, et al. Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn’s disease. Dig Liver Diseas. 2019;51:640-647. doi:10.1016/j.dld.2018.09.026

Tommelein E, Mehuys E, Tongelen I Van, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a Quantitative Measure of Adherence to Inhalation Medication in Patients With COPD. Ann Pharmacother. 2014. doi:10.1177/1060028014522982

Sampaio R, Dias CC, Horne R, Lopes JMC. Portuguese version of the Medication Adherence Report Scale (MARS‐9): Validation in a population of chronic pain patients. J Eval Clin Pract. 2019;(December 2018):346-352. doi:10.1111/jep.13098

Ueno H, Yamazaki Y, Yonekura Y, Park MJ, Ishikawa H, Kiuchi T. Reliability and validity of a 12-item medication adherence scale for patients with chronic disease in Japan. BMC Health Serv Res. 2018:1-9.

NguyenT,CazeALa,CottrellN.Validatedadherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial. BMJ. 2016:1-10. doi:10.1136/bmjopen-2016-013375

Toll BA, McKee SA, Martin DJ, Jatlow P, O’Malley SS. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. NIH. 2008;9(5):597-605. doi:10.1080/14622200701239662.Factor

Zweben A, Piepmeier ME, Fucito L, Malley SSO, Haven N. The Clinical Utility of the Medication Adherence Questionnaire (Maq) in an Alcohol PharmacotherapyTrial.HHS.2018:72-78.doi:10.1016/j. jsat.2017.04.001.The

Jankowska-pola B, Blicharska K, Uchmanowicz I, Morisky DE. The influence of illness acceptance on the adherence to pharmacological and non-pharmacological therapy in patients with hypertension. Eur J Cardiovasc Nurs. 2016. doi:10.1177/1474515115626878

Moharamzad Y, Saadat H, Shahraki BN, Rai A, Saadat Z. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015;7(4):173-183. doi:10.5539/gjhs.v7n4p173

Arnet I, Metaxas C, Walter PN, Morisky DE, Scm S, Hersberger KE. The 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients. J Eval Clin Pract. 2015;21:271-277. doi:10.1111/jep.12303

Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the Polish version of the eight-item Morisky Medication Adherence Scale in hypertensive adults. Dove Press J Patient Prefer Adherence. 2016:1759-1766.

Gallagher BD, Muntner P, Moise N, et al. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication non-adherence? HHS. 2016;33(March 2013):1108-1113. doi:10.1097/ HJH.0000000000000503.Are

Cabral AC, Moura-ramos M, Castel-branco M, Fernandez-llimos F, Figueiredo I V. Cross-cultural adaptation and validation of a European Portuguese version of the 8-item Morisky medication. Rev Port Cardiol. 2018;37(4):297-303. doi:10.1016/j. repc.2017.09.017

Amaral O, Chaves C, Duarte J, Coutinho E, Nelas P. Treatment adherence in hypertensive patients - a cross-sectional study. Procedia - Soc Behav Sci. 2015;171:1288-1295.doi:10.1016/j.sbspro.2015.01.243

Delgado A, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicol SAÚDE DOENÇAS. 2001;2(2):81-100.

Rodrigues A, Aparecida R, Dantas S. Adaptação e validação de uma medida de adesão à terapia de anticoagulação oral. Rev Lat Am Enfermagem. 2010;18(3):3-10.

Cabral AC, Moura-ramos M, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo I V. Influence of the mode of administration on the results of medication adherence questionnaires. J Eval Clin Pract. 2017;(November 2016):1252-1257. doi:10.1111/ jep.12773

Kelly MS, Moczygemba LR, Gatewood SS. Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale. J Pharm Pract. 2016;29(3):194-198. doi:10.1177/0897190014550003

Garzón NE, Patricia L. Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertention. Investig y Educ en Enfermería. 2019;37. doi:10.17533/udea.iee.v37n3e09.Vol.

Bennett SJ, Milgrom LB, Champion V, Huster GA. Beliefs about medication and dietary compliance in people with heart failure: An instrument development study. Hear Lung. 1997;26(4).

Thomason MM, Poulopoulos N, Nguyen E, Gumidyala AP, Kahn SA, Greenley RN. Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease. J Child Heal Care. 2017. doi:10.1177/1367493517712115

Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens. 2001;15:S65-S68. doi:10.1038/sj.jhh.1001081

Mardby A-C, Akerlind I, Jorgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69:158-164. doi:10.1016/j.pec.2007.08.011

Jimenez K, Vargas C, Garcia K, Guzman H, Angulo M, Billimek J. Evaluating the Validity and Reliability of the Beliefs About Medicines Questionnaire in Low-Income, Spanish-Speaking Patients with Diabetes in the United States. Diabetes Educ. 2018;43(1):114-124. doi:10.1177/0145721716675740.Evaluating

Beck E-M,Vogelin R,Wirtz M,Cavelti M,Kvrgic S, Vauth R. Do Patients With Schizophrenia Distinguish Between Attitudes Toward Antipsychotic Medication and Pharmacotherapy in General? Validation of the Beliefs About Medication Questionnaire. J Nerv Ment Dis. 2012;200(1). doi:10.1097/ NMD.0b013e31823e5875

VerhagenAP.BeliefsaboutMedicineQuestionnaire. J Physiother. 2018;64(1):60. doi:10.1016/j. jphys.2017.04.006

Sweileh WM, Zyoud SH, Abu RJ, Deleq MI, Enaia MI. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014:1-8.

Salgado T, Marques A, Geraldes L, Benrimoj S, Horne R, Fernandez-Llimos F. Adaptação transcultural do Beliefs about Medicines Questionnaire para o Português. Sao Paulo Med J. 2013;131(2):88-94. doi:10.1590/S1516-31802013000100018

Thorneloe RJ, Griffiths CEM, Ashcroft DM, Cordingley L. The challenges of assessing patients’ medication beliefs: a qualitative study. BMC Health Serv Res. 2017:1-11. doi:10.1186/s12913-017-2020-y

Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Br Soc Rheumatol. 2005:762-767. doi:10.1093/ rheumatology/keh587

Park HY, Seo SA, Yoo H, Lee K. Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Dove Press J Patient Prefer Adherence. 2018:175-181.

ClyneB,CooperJA,BolandF,HughesCM,FaheyT, Smith SM. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract. 2017;( July):507-518.

Hong SH. Potential for physician communication to build favorable medication beliefs among older adults with hypertension: A cross-sectional survey. PLoS One. 2019:1-12.

Koster ES, Heerdink ER, Vries TW de, Bouvy ML. Attitudes towards medication use in a general population of adolescents. Eur J Pediatr. 2014:483-488. doi:10.1007/s00431-013-2211-4

Wei L, Champman S, Li X, et al. Beliefs about medicines and non-adherence in patients with stroke , diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ. 2017:1-8. doi:10.1136/ bmjopen-2017-017293

Emilsson M, Berndtsson I, Gustafsson PA, Horne R. Reliability and validation of Swedish translation of Beliefs about Medication Specific (BMQ-Specific) and Brief Illness Perception Questionnaire (B-IPQ) for use in adolescents with attention-deficit hyperactivity disorder. Nord J Psychiatry. 2020;74(2):89-95. doi:10.108 0/08039488.2019.1674376

Noumani H Al, Wu J-R, Barksdale D, Knafl G, Alkhasawneh E, Sherwood G. Health Beliefs and Medication Adherence in Omanis with Hypertension. HHS - J Cardiovasc Nurs. 2019;33(6):518-526. doi:10.1097/JCN.0000000000000511.Health

Kale MS, Federman AD, Krauskopf K, et al. The Association of Health Literacy with Illness and Medication Beliefs among Patients with Chronic Obstructive Pulmonary Disease. PLoS One. 2015:1-10. doi:10.1371/journal.pone.0123937

Krauskopf K, Federman AD, Kale MS, et al. Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence. HHS - COPD. 2016;12(2):151-164. doi:10.3109/15412 555.2014.922067.Chronic

Sjölander M, Eriksson M, Glader E. The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectiona questionnaire survey. BMJ. 2013:1-8. doi:10.1136/ bmjopen-2013-003551

Horne R, Faasse K, Cooper V, et al. The perceived sensitivity to medicines (PSM) scale: An evaluation of validity and reliability. Br J Health Psychol. 2013:18-30. doi:10.1111/j.2044-8287.2012.02071.x

Dolder CR, Lacro JP, Warren KA. Brief Evaluation of Medication Influences and Beliefs: Development and TestingofaBriefScaleforMedicationAdherence.JClin Psychopharmacol. 2004;24(4):404-409. doi:10.1097/01. jcp.0000130554.63254.3a

Eakin MN, Chung S-E, Hoehn J, Borrelli B, Rand-GiovannettiD,RiekertKA.DevelopmentandValidation of CF-Medication Beliefs Questionnaire: A mixed-methods approach. HHS - J Cyst Fibros. 2018;16(5):637-644. doi:10.1016/j.jcf.2017.05.001.Development

Machado V, Alves R, Ramos C, Proença L, Cavacas MA. Psychometric properties of the Brief Illness Perception Questionnaire (Brief ‐ IPQ) in periodontal diseases. J Clin Periodontol. 2019;(May):1183-1191. doi:10.1111/jcpe.13186

Foley KA, Vasey J, Berra K, Alexander CM, Markson LE. The Hyperlipidemia: Attitudes and Beliefs in Treatment (HABIT) Survey for Patients Results of a Validation Study. J Cardiovasc Nurs. 2005;20(1):35-42.

Zebb BJ,Moore MC.Another look at the psychometric properties of the Anxiety Control Questionnaire. Behav Res Therepy. 1999;37.

OlthuisJV,WattMC,StewartSH.AnxietySensitivity Index (ASI-3) subscales predict unique variance in anxiety and depressive symptoms. J Anxiety Disord. 2014;28(2):115-124. doi:10.1016/j.janxdis.2013.04.009

ZvolenskyMJ,GareyL,FergusTA,etal.Refinementof Anxiety Sensitivity Measurement:The Short Scale Anxiety SensitivityIndex(SSASI).PsychiatryRes.2019;(713):549-557. doi:10.1016/j.psychres.2018.08.115.Refinement

Julian LJ. Measures of Anxiety. Arthritis Care Res. 2011;63:467-472. doi:10.1002/acr.20561.Measures

Aaron T. Beck, Gary Brown, Kiyosaki RT, Lechter SL. An Inventory for Measuring Clinical Anxiety: Psychometric Properties. J Consult Clin Psychol. 1988;56(6):893-897. http://citeseerx.ist.psu.edu/ viewdoc/download?doi=10.1.1.471.4319&rep=rep1&typ e=pdf%0Ahttps://pdfs.semanticscholar.org/1a3e/334f16 b6888843a8150ddf7e4f46b2b28fd5.pdf.

De Lima Osório F, Crippa JAS, Loureiro SR. Further psychometric study of the Beck Anxiety Inventory including factorial analysis and social anxiety disorder screening. Int J Psychiatry Clin Pract. 2011;15(4):255-262. doi:10.3109/13651501.2011.605955

Lee K, Kim D, Cho Y. Exploratory Factor Analysis of the Beck Anxiety Inventory and the Beck Depression Inventory-II in a Psychiatric Outpatient Population. JKMS.2018;33(16):1-11.

Oei TPS, Sawang S, Goh YW, Mukhtar F. Using the Depression Anxiety Stress Scale 21 (DASS-21) across cultures. Int J Psychol. 2013;48(6):6. doi:10.1080/002075 94.2012.755535

Weiss BJ, Calleo J, Rhoades HM, et al. The Utility Of The Generalized Anxiety Disorder Severity Scale (GADSS) With Older Adults In Primary Care. NIH - Depress Anxiety. 2009;26(1):1-13. doi:10.1002/da.20520. THE

Segal DL, June A, Payne M, Coolidge FL, Yochim B. Development and initial validation of a self-report assessment tool for anxiety among older adults: The Geriatric Anxiety Scale.J Anxiety Disord.2010;24(7):709-714. doi:10.1016/j.janxdis.2010.05.002

Massena PN, Araújo NB De, Pachana N, Laks J, Pádua AC De. Validation of the Brazilian Portuguese Version of Geriatric Anxiety Inventory – GAI-BR. Int Psychogeriatrics. 2014:1-7. doi:10.1017/ S1041610214001021

Gomez R,Summers M,Summers A,Wolf A,Summers J. Depression Anxiety Stress Scales-21: Measurement and Structural Invariance Across Ratings of Men and Women. 2014. doi:10.1177/1073191113514106

Covic T, Cumming SR, Pallant JF, et al. Depression and Anxiety in Patients with Rheumatoid Arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale ( DASS ) and the Hospital, Anxiety and Depression Scale ( HADS ). BMC Psychiatry. 2012;12(1):6. doi:10.1186/1471-244X-12-6

Zimmerman M, Martin J, Clark H, Mcgonigal P, Harris L, Holst CG. Measuring anxiety in depressed patients: A comparison of the Hamilton anxiety rating scale and the DSM-5 Anxious Distress Specifier Interview. J Psychiatr Res. 2017;93:59-63. doi:10.1016/j. jpsychires.2017.05.014

Belk RA, Pilling M, Rogers KD, Lovell K, Young A. The theoretical and practical determination of clinical cut-offs for the British Sign Language versions of PHQ-9 and GAD-7. BMC Psychiatry. 2016;(December 2011):1-12. doi:10.1186/s12888-016-1078-0

SchaletBD,CookKF,ChoSW,CellaD.Establishing a Common Metric for Self-Reported Anxiety: Linking the MASQ, PANAS, and GAD-7 to PROMIS Anxiety. J Anxiety Disord. 2015;28(1):88-96. doi:10.1016/j.janxdis.2013.11.006.Establishing

Ball SG, Lipsius S, Escobar R. Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder. Int Psychogeriatrics. 2015:1533-1539. doi:10.1017/ S1041610215000381

Rozzini R,Trabucchi M.Use of the Geriatric Anxiety Inventory – short form as a screening tool for detection of generalised anxiety in a memory clinic population. 2013;31:2012-2013. doi:10.1002/gps.3897

Mueller AE, Segal DL, Gavett B, et al. Geriatric Anxiety Scale : item response theory analysis, differential item functioning , and creation of a ten-item short form (GAS-10). Int Psychogeriatrics. 2014:1-13. doi:10.1017/ S1041610214000210

Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Chic Ill). 2015;(April):2015. doi:10.1093/occmed/kqv054

Correia DT, Barbosa A. Ansiedade e Depressão em Medicina: Modelos Teóricos e Avaliação. Acta Med Port. 2009:89-98.

Herrmann C. International Experiences With The Hospital Anxiety And Depression Scale - A Review Of Validation Data And Clinical Results. J Psychosom Res. 1997;42.

Beekman E, Verhagen A. Clinimetrics: Hospital Anxiety and Depression Scale. J Physiother. 2018;64(3):198. doi:10.1016/j.jphys.2018.04.003

Stern AF. The Hospital Anxiety and Depression Scale. Occup Med (Chic Ill). 2014:393-394. doi:10.1093/ occmed/kqu024

Sousa C, Pereira MG. Morbilidade psicológica e representações da doença em pacientes com esclerose múltipla: Estudo de validação da “Hospital Anxiety and Depression Scale” (HADS). Psicolofia, Saúde & Doenças. 2008;9(2):283-298.

Beard C, Rodriguez BF, Moitra E, Sibrava NJ, Weisberg RB, Keller MB. Psychometric Properties of the Liebowitz Social Anxiety Scale (LSAS) in a Longitudinal Study of African Americans with Anxiety Disorders. J Anxiety Disord. 2012;25(5):722-726. doi:10.1016/j.janxdis.2011.03.009.Psychometric

Glischinski M von, Willutzki U, Stangie U, et al. Liebowitz Social Anxiety Scale (LSAS): Optimal cut points for remission and response in a German sample. Clin Psychol Psychother. 2018;( January):465-473. doi:10.1002/cpp.2179

Wardenaar KJ, Veen T Van, Giltay EJ, Beurs E De, Penninx BWJH, Zitman FG. Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ). Psychiatry Res. 2010;179(1):101-106. doi:10.1016/j. psychres.2009.03.005

Buckby JA, Yung AR, Cosgrave EM, Cotton SM. Distinguishing between anxiety and depression using the Mood and Anxiety Symptoms Questionnaire (MASQ). Br J Clin Psychol. 2007:235-239. doi:10.1348/014466506X132912

Thaler NS, Kazemi E, Wood JJ. Measuring Anxiety in Youth with Learning Disabilities : Reliability and Validity of the Multidimensional Anxiety Scale for Children(MASC).ChildPsychiatryHumDev.2010:501- 514. doi:10.1007/s10578-010-0182-5

Ólason DT, Sighvatsson MB, Smári J, Masc C. Psychometric properties of the Multidimensional Anxiety Scale for Children (MASC) among Icelandic schoolchildren. Scand J Psychol. 2004;(Cdi):429-436.

March JS, Sullivan K. Test-Retest Reliability of the Multidimensional Anxiety Scale for Children. J Anxiety Disord. 1999;13(4):349-358.

Piqueras JA, Martín-vivar M, Sandin B, San C, Pineda D. The Revised Child Anxiety and Depression Scale: A systematic review and reliability generalization meta-analysis. J Affect Disord. 2017;218(December 2016):153-169. doi:10.1016/j.jad.2017.04.022

Morales A,Reis S,Espada JP,Orgilés M.Portuguese validation of the Short Health Anxiety Inventory: Factor structure , reliability, and factor invariance. J Health Psychol. 2018. doi:10.1177/1359105316669859

Ranta K, Junttila N, Laakkonen E, Uhmavaara A, Greca AM La. Social Anxiety Scale for Adolescents (SAS-S): Measuring Social Anxiety Among Finnish Adolescents. Child Psychiatry Hum Dev. 2012:574-591. doi:10.1007/s10578-012-0285-2

Pechorro P, Ayala-Nunes L, Nunes C, Marôco J, Gonçalves RA. The Social Anxiety Scale for Adolescents: Measurement Invariance and Psychometric Properties Among a School Sample of Portuguese Youths. Child Psychiatry Hum Dev. 2016;47(6):975-984. doi:10.1007/s10578-016-0627-6

Heidenreich T, Schermelleh-Engel K, Schramm E, Hofmann SG, Stangier U. The factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale. J Anxiety Disord. 2011;25(4):579-583. doi:10.1016/j.janxdis.2011.01.006

Orgilés M, Méndez X, Spence SH, Huedo-Medina TB, Espada JP. Spanish Validation of the Spence Children’s Anxiety. Child Psychiatry Hum Dev. 2012:271-281. doi:10.1007/s10578-011-0265-y

Whiteside SP, Brown AM. Exploring the utility of the Spence Children’s Anxiety Scales parent-and child-report forms in a North American sample. J Anxiety Disord. 2008;22:1440-1446. doi:10.1016/j. janxdis.2008.02.006

Orgilés M, Penosa P, Fernández‐Martínez I, Marzo JC, Espada JP. Spanish validation of the Spence Preschool Anxiety Scale. 2018;(October 2017):753-758. doi:10.1111/cch.12593

Fernández-Blázqueza MA, Ávila-Villanueva M, López-Pina JA, Frades-Payo B, Zea-Sevilla MA. Propiedades psicométricas de una nueva versión abreviada del State-Trait Anxiety Inventory (STAI) para valorar el nivel de ansiedad en personas mayores. Neurología. 2015;30(6):352-358.

Andrade L, Gorenstein C, Vieira Filho AH, Tung TC, Artes R. Psychometric properties of the Portuguese version of STAI Brazilian. J Med Biol Res. 2001;34(3):367-374.

Downloads

Publicado

2024-06-10

Como Citar

1.
Coelho R, Herdeiro MT, Vitória Figueiredo I, Cabral AC. RELAÇÃO ENTRE ANSIEDADE, CRENÇAS NA MEDICAÇÃO E ADESÃO À TERAPÊUTICA EM DOENTES COM DOENÇA CARDIOVASCULAR. RH [Internet]. 10 de Junho de 2024 [citado 22 de Julho de 2024];(101):5-19. Disponível em: https://revistahipertensao.pt/index.php/rh/article/view/128

Edição

Secção

Artigo Original